Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1350
+0.0100 (8.00%)
Aug 15, 2025, 3:59 PM EDT
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 14.39 million as of August 15, 2025. Its market cap has increased by 49.43% in one year.
Market Cap
14.39M
Enterprise Value
13.15M
Revenue
420.81K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 14.39M, an increase of 116.75%. That is a compound annual growth rate of 24.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 14.39M | -44.30% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.23B |
| Green Thumb Industries | 2.83B |
| Trulieve Cannabis | 2.38B |
| Sienna Senior Living | 1.69B |
| dentalcorp Holdings | 1.61B |
| Cronos Group | 1.39B |
| WELL Health Technologies | 1.27B |
| Extendicare | 1.13B |